NCT06435429 2026-02-10A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast CancerJazz PharmaceuticalsPhase 3 Recruiting550 enrolled